High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

Clinical Trial ID NCT00936936

PubWeight™ 2.93‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00936936

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. Ann Oncol 2015 1.39
2 Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol 2014 0.78
3 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100